Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EDIT | NAGE | NMRA | ||
| Company | Editas Medicine | Niagen Bioscience Inc | Neumora Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.76 | 3.39 | 1.6000 | ||
| High | 2.96 | 3.57 | 1.6000 | ||
| Low | 2.76 | 3.38 | 1.4000 | ||
| Latest | 2.80 | 3.45 | 1.4600 | ||
| Change | +0.04 | +0.07 | -0.1500 | ||
| % Change | +1.45% | +2.07% | -9.32% | ||
| Volume | 3,815,700 | 564,800 | 2,212,300 | ||
| 20-Day Average Volume | 3,493,305 | 726,105 | 3,515,110 | ||
| Previous Close | 2.76 | 3.38 | 1.6100 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.81 | 3.52 | 1.6412 | ||
| 20-Day Raw Stochastic | 28.30% | 14.71% | 55.74% | ||
| 20-Day Relative Strength | 50.56 | 40.01 | 42.80 | ||
| Weighted Alpha | +1.78 | -71.48 | -38.23 | ||
| Today's Opinion | 24% Buy | 100% Sell | 88% Sell | ||
| Previous Opinion | 24% Buy | 100% Sell | 88% Sell | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.64% since 06/16/26 | +0.58% since 06/16/26 | -6.41% since 06/16/26 | ||
| Low | 2.39 on 06/17/26 | 3.36 on 06/17/26 | 1.3200 on 06/17/26 | ||
| High | 2.96 on 06/24/26 | 3.57 on 06/24/26 | 1.6500 on 06/23/26 | ||
| 1-Month | |||||
| %Chg | +1.45% since 05/22/26 | -5.74% since 05/22/26 | -21.08% since 05/22/26 | ||
| Low | 2.35 on 06/16/26 | 3.35 on 06/08/26 | 0.8302 on 06/15/26 | ||
| High | 3.94 on 05/27/26 | 4.04 on 05/26/26 | 1.9600 on 05/29/26 | ||
| 3-Month | |||||
| %Chg | +24.44% since 03/24/26 | -24.01% since 03/24/26 | -40.89% since 03/24/26 | ||
| Low | 2.13 on 03/30/26 | 3.35 on 06/08/26 | 0.8302 on 06/15/26 | ||
| High | 3.94 on 05/27/26 | 5.12 on 05/04/26 | 2.6150 on 03/25/26 | ||
| 6-Month | |||||
| %Chg | +26.70% since 12/24/25 | -47.81% since 12/24/25 | -19.34% since 12/24/25 | ||
| Low | 1.66 on 02/05/26 | 3.35 on 06/08/26 | 0.8302 on 06/15/26 | ||
| High | 3.94 on 05/27/26 | 6.86 on 01/07/26 | 3.6500 on 02/18/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 274,137 | 274,772 | 270,515 | ||
| Shares Outstanding, K | 97,906 | 79,644 | 185,284 | ||
| Annual Sales | 40,520,000 | 129,420,000 | 0 | ||
| Annual Net Income | -160,060,000 | 17,380,000 | -236,930,000 | ||
| Last Quarter Sales | 2,830,000 | 31,470,000 | 0 | ||
| Last Quarter Net Income | -24,980,000 | 6,320,000 | -53,460,000 | ||
| 60-Month Beta | 2.16 | 2.08 | 2.73 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.26 on 05/05/26 | 0.07 on 05/06/26 | -0.30 on 05/07/26 | ||
| Earnings Date | 08/11/26 | 08/05/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.79 | 0.00 | ||